Among the 15 patients with bilateral or second primary breast cancer; 10 (66.7%) had deleterious or suspected deleterious BRCA1/2 mutations; 5 (33.3%) were in BRCA2 and 5 (33.3) in BRCA1. Here, BRCA2 is linked to breast cancer.